Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2009
10/13/2009CA2379666C Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
10/13/2009CA2373867C Compositions comprising organosiloxane resins for delivering oral care substances
10/13/2009CA2367615C Transdermal therapeutic system with nicotine and addition of monoterpene ketones
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/08/2009WO2009124300A2 Solid state forms of a pharmaceutical
10/08/2009WO2009124103A2 Combination therapies comprising par1 antagonists with par4 antagonists
10/08/2009WO2009124046A1 Suture line administration technique using botulinum toxins
10/08/2009WO2009124022A1 2 -aminotetralin derivatives as mu opioid receptor antagonists
10/08/2009WO2009123986A1 Apoptosis signal-regulating kinase 1 inhibitors
10/08/2009WO2009123881A1 Purine derivatives as a3 receptor- selective agonists
10/08/2009WO2009123877A1 A method of treating a nervous system disorder by modulation of neurogenesis with mcc-257
10/08/2009WO2009123855A1 3-indazolyl-4-pyridylisothiazoles
10/08/2009WO2009123714A2 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
10/08/2009WO2009123569A1 Method for treating neurological disorders with imidazolium and imidazolinium compounds
10/08/2009WO2009123537A1 GABAa RECEPTOR MODULATORS
10/08/2009WO2009123536A1 NEW CLASSES OF GABAa/BZR LIGANDS
10/08/2009WO2009123487A1 Compounds for treating pain
10/08/2009WO2009123486A1 Use of compounds in the treatment of tau-induced cytotoxicities
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof
10/08/2009WO2009122707A1 1,3-dihydroisobenzofuran derivative
10/08/2009WO2009122580A1 Method of bioassaying yokukansan
10/08/2009WO2009122301A2 Rasagiline mesylate particles and process for the preparation thereof
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009WO2009121959A1 Use of glycosaminoglycan for restoring glycocalyx
10/08/2009WO2009121914A1 Substituted piperidines as therapeutic compounds
10/08/2009WO2009121910A1 Indene derivatives as estrogen receptor ligands
10/08/2009WO2009121872A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009WO2009121812A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
10/08/2009WO2009121759A2 Use of pegylated igf-i variants for the treatment of neuromuscular disorders
10/08/2009WO2009121176A1 Insulin-induced gene (insig) peptide compositions and methods for cytoprotection
10/08/2009WO2009121175A1 Use of enteric glia
10/08/2009WO2009093210A3 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a]PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
10/08/2009WO2009093209A3 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR d] PYRAZOLO [1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
10/08/2009WO2009091932A3 Treatment of mild dementia of the alzheimer's disease type
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009WO2009019295A3 Phenyl- and benzylthiazolylpiperazine derivatives for the treatment of neurodegenerative diseases
10/08/2009WO2008108286A9 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
10/08/2009WO2008104385A8 Method for the treatment of amyloidoses
10/08/2009WO2008101412A8 The use of epimedium flavones and effective components thereof for the preparation of medicaments of promoting proliferations and differentiations of nerve cells
10/08/2009WO2008080844A9 Azaspiro derivatives
10/08/2009WO2007124849A3 Inhibitors of the task-1 and task-3 ion channel
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090255003 Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases
10/08/2009US20090255001 Parkinson's Disease-Related Gene GRK5 and Uses Thereof
10/08/2009US20090253807 Aqueous suspension preparations
10/08/2009US20090253787 Short-acting sedative hypnotic agents for anesthesia and sedation
10/08/2009US20090253783 Production of Delta 9 Tetrahydrocannabinol
10/08/2009US20090253782 Compounds for Enhancing Arginase Activity and Methods of USe Thereof
10/08/2009US20090253781 Therapeutic compositions
10/08/2009US20090253768 Therapeutic compounds for diseases and disorders
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253756 Indole Amide Derivatives as EP4 Receptor Antagonists
10/08/2009US20090253753 Therapeutic Use of Acylaminothiazole Derivatives
10/08/2009US20090253750 3-indazolyl-4-pyridylisothiazoles
10/08/2009US20090253747 Remedy for sleep disturbance
10/08/2009US20090253737 Certain chemical entities, compositions, and methods
10/08/2009US20090253736 Azaindole derivatives as cftr modulators
10/08/2009US20090253735 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
10/08/2009US20090253732 Production Of Polyketides And Other Natural Products
10/08/2009US20090253731 Method of identifying therapeutic agents
10/08/2009US20090253730 Method and composition for deterring abuse of opioid containing dosage forms
10/08/2009US20090253729 Analgesic Agent
10/08/2009US20090253728 Methods and Compositions for Treating Nociceptive Pain
10/08/2009US20090253727 Nociceptin analogs
10/08/2009US20090253716 Amino-imidazolones for the inhibition of beta-secretase
10/08/2009US20090253711 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/08/2009US20090253710 NMDA Receptor Antagonists for Neuroprotection
10/08/2009US20090253702 Fast acting naratriptan composition
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253700 N-'4-4(4-morpholinyl) phenyl!- '(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009US20090253698 Brain, Spinal and Nerve Injury Treatment
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253689 Organic Compounds
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253678 Macrocyclic pyrimidine derivatives
10/08/2009US20090253670 nicotinic receptor modulators such as N-[3-(1H-pyrrol-1-yl)benzyl]-4-[(trifluoromethyl)thio]benzamide, useful for treating and preventing a condition or disorder affecting cognition, neurodegeneration and schizophrenia
10/08/2009US20090253637 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein disorders
10/08/2009US20090253625 GLP-1, exendin-4, peptide analogs and uses thereof
10/08/2009US20090253623 Gh secretagogues and uses thereof
10/08/2009US20090253622 Use of tlr3 agonists for the treatment of neurodegenerative disorders
10/08/2009US20090253617 Diagnosis and treatment of attentional disorders
10/08/2009US20090252816 Inhalable Gaseous Medicament Based On Xenon And Nitrous Oxide
10/08/2009US20090252793 Pharmaceutical compositions
10/08/2009US20090252786 Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
10/08/2009US20090252777 Method for formulating a controlled-release pharmaceutical formulation
10/08/2009US20090252764 Suture line administration technique using botulinum toxin
10/08/2009US20090252758 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
10/08/2009US20090252744 Methods for Treating Bone Cancer Pain by Administering A Nerve Growth Factor Antagonist antibody
10/08/2009US20090252724 Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region
10/08/2009US20090252717 Compositions and Methods for Treating Polyglutamine-Expansion Neurodegenerative Diseases
10/08/2009US20090252714 Autoantigenes for Improved Diagnosis, Prognosis and Treatment of Inflammatory Neurological Diseases
10/08/2009CA2720464A1 Gabaa receptor modulators
10/08/2009CA2720461A1 New classes of gabaa/bzr ligands
10/08/2009CA2720408A1 Use of pegylated igf-i variants for the treatment of neuromuscular disorders
10/08/2009CA2720375A1 Compounds for treating pain
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 1833